These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35920471)

  • 1. Clinical and parasitological impact of short-term treatment using miltefosine and allopurinol monotherapy or combination therapy in canine visceral leishmaniasis.
    Ayres EDCBS; Dias ÁFLR; Monteiro BRG; Pazzini SS; Barbosa MEC; Silva EBD; Macedo LFDC; Sousa VRF; Dutra V; Nakazato L; Almeida ADBPF
    Rev Bras Parasitol Vet; 2022; 31(3):e007222. PubMed ID: 35920471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of the use of miltefosine, miltefosine plus allopurinol, and allopurinol in dogs with visceral leishmaniasis.
    Dias ÁFLR; Ayres EDCBS; de Oliveira Martins DT; Maruyama FH; de Oliveira RG; de Carvalho MR; Almeida ADBPF; Teixeira ALS; Mendonça AJ; Sousa VRF
    Exp Parasitol; 2020 Oct; 217():107947. PubMed ID: 32628971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil.
    Dos Santos Nogueira F; Avino VC; Galvis-Ovallos F; Pereira-Chioccola VL; Moreira MAB; Romariz APPL; Molla LM; Menz I
    Parasit Vectors; 2019 Feb; 12(1):79. PubMed ID: 30736866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol.
    Gonçalves G; Campos MP; Gonçalves AS; Medeiros LCS; Figueiredo FB
    Parasit Vectors; 2021 Dec; 14(1):599. PubMed ID: 34886876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.
    Manna L; Vitale F; Reale S; Picillo E; Neglia G; Vescio F; Gravino AE
    Vet J; 2009 Dec; 182(3):441-5. PubMed ID: 18818112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of Artesunate in the treatment of visceral leishmaniasis in dogs naturally infected by Leishmania infantum: Efficacy evidence from a randomized field trial.
    Medkour H; Bitam I; Laidoudi Y; Lafri I; Lounas A; Hamidat HK; Mekroud A; Varloud M; Davoust B; Mediannikov O
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008947. PubMed ID: 33338041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.
    Pasa S; Toz SO; Voyvoda H; Ozbel Y
    Vet Parasitol; 2005 Mar; 128(3-4):243-9. PubMed ID: 15740861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine leishmaniosis: in vitro efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantum.
    Farca AM; Miniscalco B; Badino P; Odore R; Monticelli P; Trisciuoglio A; Ferroglio E
    Parasitol Res; 2012 Jun; 110(6):2509-13. PubMed ID: 22218923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.
    Manna L; Corso R; Galiero G; Cerrone A; Muzj P; Gravino AE
    Parasit Vectors; 2015 May; 8():289. PubMed ID: 26017164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma (INF-gamma), IL4 expression levels and Leishmania DNA load as prognostic markers for monitoring response to treatment of leishmaniotic dogs with miltefosine and allopurinol.
    Manna L; Reale S; Picillo E; Vitale F; Gravino AE
    Cytokine; 2008 Nov; 44(2):288-92. PubMed ID: 18842424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic success and failure in using miltefosine to treat dogs naturally infected with Leishmania infantum.
    Gonçalves G; Campos MP; Gonçalves AS; Figueiredo FB
    Rev Bras Parasitol Vet; 2024; 33(1):e015023. PubMed ID: 38359300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of miltefosine for the treatment of dogs naturally infected with L. infantum (=L. chagasi) in Brazil.
    Andrade HM; Toledo VP; Pinheiro MB; Guimarães TM; Oliveira NC; Castro JA; Silva RN; Amorim AC; Brandão RM; Yoko M; Silva AS; Dumont K; Ribeiro ML; Bartchewsky W; Monte SJ
    Vet Parasitol; 2011 Sep; 181(2-4):83-90. PubMed ID: 21641721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Canine leishmaniasis: evolution of the chemotherapeutic protocols].
    Oliva G; Foglia Manzillo V; Pagano A
    Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases).
    Denerolle P; Bourdoiseau G
    J Vet Intern Med; 1999; 13(5):413-5. PubMed ID: 10499722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
    Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L
    Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First study on efficacy and tolerability of a new alkylphosphocholine molecule (oleylphosphocholine-OlPC) in the treatment of canine leishmaniosis due to Leishmania infantum.
    Hernández L; Gálvez R; Montoya A; Checa R; Bello A; Bosschaerts T; Jansen H; Rupérez C; Fortin A; Miró G
    Parasitol Res; 2014 Jan; 113(1):157-64. PubMed ID: 24192865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy.
    de Jong MK; Rappoldt A; Broere F; Piek CJ
    Parasit Vectors; 2023 May; 16(1):163. PubMed ID: 37189181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us.
    Travi BL; Cordeiro-da-Silva A; Dantas-Torres F; Miró G
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006082. PubMed ID: 29324838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scientometric analysis of chemotherapy of canine leishmaniasis (2000-2020).
    Olías-Molero AI; Fontán-Matilla E; Cuquerella M; Alunda JM
    Parasit Vectors; 2021 Jan; 14(1):36. PubMed ID: 33422141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new immunochemotherapy schedule for visceral leishmaniasis in a hamster model.
    de Santana FR; da Silva DAM; Katz S; Orikaza CM; Oliveira KC; Barbiéri CL
    Parasitol Res; 2022 Oct; 121(10):2849-2860. PubMed ID: 35997843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.